Key facts
- Notable investors include MedTech Innovator, National Institutes of Health, Empire State Development, Cornell University, Duke University — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Conform Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Conform Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Conform Medical
Developer of a catheter-based technology designed to improve the precision and safety of cardiac arrhythmia mapping and ablation procedures. The company offers soft robotic technology with active conformability, compliance, resizability, and multi-functionality, enabling electrophysiologists and interventional cardiologists to treat complex heart structures effectively and with reduced risk, time, and cost.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Employees
- 4
- Website
- conformmedical.com/
- Ownership
- Privately Held (backing)
Conform Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Conform Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Conform Medical in its N-PORT filings yet. We sweep new filings monthly.